Jinhua Given Cough Treatment Of Acute Tracheal Particles - Bronchitis Phlegm Heat Permits The Evaluation Of Efficacy

Objection: Chinese medicine agents treat acute tracheitis and bronchitis by many ways. It has many superiorities such as refine, cheap, safety and so on. At present, because of lacking randomized, blind , control and large sample researches, it is hard to appreciate the therapy of Chinese medicine agents and restrain the use of them. With the principles of randomization, blinding and control, the clinical research appreciates the efficacy of JinHuaDingKe granule to treat acute tracheitis and bronchitis.Method: The clinical research method is based on extensively reviewing theory and documents, demonstrating the refine of the drugs and its modern pharmacologic action . With the principles of randomization, blinding and control, the clinical trial chooses acute tracheitis and bronchitis of sputum and heat as the diseases of adaptation, to appreciate the efficacy of JinHuaDingKe granule.Result: There is no statistic significance between the test group and control group at the change scores of the primary signs , positive symptoms and total efficacy. The efficacy of JinHuaDingKe group is 78.90%, and QingReZhiKe group is 83.04%. It has statistic significance in non-inferiority analysis between the test group and control group. The 95% confidence interval (CL) is -4.21.And it also has statistic significance in non- inferiority analysis between the control group and the test group . The 95% confidence interval (CL) CL is 4.06.Innovation: According to the principles of randomization, blinding, control and large sample, using non-inferiority analysis, the research appreciates the efficacy of JinHuaDingKe.Problem: The research uses signs and symptoms as main therapeutic indexes. If we can not obey the standard operating procedure seriousely, it is easy to make bias.